menu search

Medtronic stock is simply too cheap to ignore

Medtronic is a global medical technology company specializing in various medical devices. The company's revenues are well distributed among different ...

October 29, 2023, 5:07 am

Merit medical (mmsi) q3 earnings top estimates, fy23 view revised

Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its cardi...

October 27, 2023, 12:47 pm

Shockwave medical announces details for conference call discussing third quarter 2023 results and participation in upcoming investor conference

SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of t...

October 26, 2023, 4:30 pm

Why is lianbio (lian) stock up 130% today?

Shares of LianBio (NASDAQ: LIAN ) — which focuses on “developing and commercializing medicines for cardi...

October 24, 2023, 1:48 pm

Us equities set to break the trend of monday gains

S&P 500 futures are down 0.46% just ahead of the open. They were trading higher through most of Asian trading but fell as Europe arrived then staged a...

October 23, 2023, 1:22 pm

Mallinckrodt to present data on terlivaz® (terlipressin) for injection in adult patients with hepatorenal syndrome (hrs) at the american college of gastroenterology (acg) annual scientific meeting

– Findings from two clinical studies and one health economic database analysis provide insight into HRS treatment outcomes with TERLIVAZ,1 patients'...

October 22, 2023, 3:05 pm

Tourmaline bio announces closing of merger with talaris therapeutics and concurrent private placement of $75 million

Tourmaline will be focused on advancing TOUR006, its differentiated anti-IL-6 antibody, to treat thyroid eye disease (TED), atherosclerotic ...

October 19, 2023, 9:37 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.(alny)

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 19, 2023, 5:13 pm

Intellia's (ntla) ind for gene-editing therapy gets fda clearance

Intellia (NTLA) gets FDA nod to begin a phase III study on its gene editing candidate, NTLA-2001 to treat transthyretin amyloidosis with ...

October 19, 2023, 12:47 pm

Arca biopharma announces third quarter 2023 financial results

Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic option...

October 18, 2023, 8:25 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam Pharmaceuticals, In...

October 17, 2023, 10:06 pm

Cyclarity therapeutics announces clinical advisory board

NOVATO, Calif, Oct. 17, 2023 (GLOBE NEWSWIRE) — Cyclarity Therapeutics, Inc. (https://cyclaritytx.com), today announced its newly formed Clinical Ad...

October 17, 2023, 10:04 pm

Neurobo to present at the h.c. wainwright 7th annual nash investor conference

BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform ...

October 17, 2023, 8:01 am

89bio to participate in the h.c. wainwright 7ᵗʰ annual nash investor conference

SAN FRANCISCO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

October 17, 2023, 8:00 am

: novo nordisk to buy hypertension treatment from for $1.3 billion from kbp biosciences

Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is...

October 16, 2023, 11:11 am

Novo nordisk buys blood pressure treatment to bolster diabtetes portfolio

Novo Nordisk (NYSE:NVO) has agreed to buy ocedurenone, a blood pressure drug for with potential applications in ...

October 16, 2023, 10:44 am

Novo nordisk buys hypertension drug in $1.3 billion deal

Novo Nordisk (NVO) agreed to buy ocedurenone, a drug that treats uncontrolled hypertension and has the potential to be used in cases of ...

October 16, 2023, 9:50 am

5 stocks that brokers favor despite the ongoing uncertainty

We believe that stocks like Rev Group (REVG), CVR Energy (CVI), cardinal Health (CAH), Commercial Vehic...

October 16, 2023, 9:47 am

Novo nordisk in $1.3 bln deal to buy hypertension drug

Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in ...

October 16, 2023, 7:12 am


Search within

Pages Search Results: